Dexpanthenol 250mg/mL
Lack of Assurance of Sterility
268 recalls, newest first
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.
Chemical contamination: Presence of benzene
Chemical contamination: Presence of benzene
Chemical contamination: Presence of benzene
Labeling - product contains undeclared ethyl alcohol
Labeling - product contains undeclared ethyl alcohol
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.
CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.